[1]Iguchi Y,Kimura K,Aoki J,et al.Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city [J]. Circ J,2008,72(6):909-913.
[2]Numa S,Hirai T,Nakagawa K,et al.Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk [J]. Circ J,2014,78(7):1600-1605.
[3]Ferrari R,Bertini M,Blomstrom-Lundqvist C, et al.An update on atrial fibrillation in 2014: From pathophysiology to treatment [J]. Int J Cardiol,2016,203(1):22-29.
[4]易茜,蹇朝,李勇,等.氧化应激标志物在房颤患者心房结构重构中的变化及意义 [J]. 第三军医大学学报,2015,37(1):55-59.
[5]Hu YF,Chen YJ,Lin YJ,et al.Inflammation and the pathogenesis of atrial fibrillation [J]. Nat Rev Cardiol,2015,12(4):230-243.
[6]Harada M,Van Wagoner DR,Nattel S.Role of inflammation in atrial fibrillation pathophysiology and management [J]. Circ J,2015,79(3):495-502.
[7]Feig DI,Kang DH,Johnson RJ. Uric acid and cardiovascular risk [J]. N Engl J Med,2008,359(17):1811-1821.
[8]Bombelli M, Ronchi I, Volpe M, et al. Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality [J]. J Hypertens, 2014,32(6):1237-1244.
[9]Tekin G,Tekin YK,Erbay AR,et al.Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure [J]. Angiology,2013,64(4):300-303.
[10]Ndrepepa G, Braun S, King L, et al. Association of uric acid with mortality in patients with stable coronary artery disease [J]. Metabolism, 2012,61(12):1780-1786.
[11]Nyrnes A,Toft I,Mathiesen EB,et al.Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study [J]. Europace,2014,16(3):320-326.
[12]Tamariz L, Agarwal S, Soliman EZ, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study) [J]. Am J Cardiol, 2011,108(9):1272-1276.
[13]Dudley SC,Hoch NE,McCann LA,et al.Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases [J]. Circ J,2005,112(9):1266-1273.
[14]Liu Y,Liu H,Dong L,et al.Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the Peoples Hospital of Peking University [J]. Acta Cardiol,2010,65(2):221-224.
[15]Letsas KP, Korantzopoulos P, Filippatos GS,et al.Uric acid elevation in atrial fibrillation [J]. Hellenic J Cardiol,2010,51(3):209-213.
[16]Koide Y,Yotsukura M,Sakata K,et al.Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation [J]. Clin Cardiol,2002,25(2):69-75.
[17]Parkash R,Green MS,Kerr CR,et al.The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation [J]. Am Heart J,2004,148(4):649-654.
[18]Wozakowska-Kapon B.Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period [J]. Int J Cardiol,2005,101(1):47-52.